OBJECTIVES Evaluating the characters of cause of death of the hospitalized geriatric adults to identify their mortality patterns, providing the evidence for the therapy strategy for management of the hospitalized adults aged 80 and older.
METHODS A longitudinal study in a routine health check-up population was performed according to an average of 4.8 years' follow-up. The demographic information and anthropometric parameters at baseline were obtained. The baseline and the follow-up arterial stiffness (pulse-wave velocity, PWV) and biomarker variables including UA were measured. Pearson's correlations and regressions were used to identify the relationship between UA and arterial stiffness. Plasma UA levels at baseline was categorized by its quartiles [Quartile 1 ( 238.95 mmol/L, n ¼ 370), Quartile 2 (239-284.60 mmol/L, n ¼352), Quartile 3 (284.61-341.85 mmol/L, n ¼372), and Quartile 4 (! 341.90mmol/L, n ¼ 353)] for further analyses by Logistic regression to determine the risk factors and predictors for arterial stiffness.
RESULTS A total of 1447 valid follow-ups were available for the analyses. UA was closely associated with arterial stiffness both at baseline and follow-up: carotid-femoral PWV (cf-PWV: r ¼ 0.154, p < 0.001 and r ¼ 0.153, p < 0.001, respectively) and carotid-radial PWV (cr-PWV: r ¼ 0.140, p <0.001 and r ¼ 0.145, p <0.001, respectively). Multiple regressions also indicated the relationship between UA and arterial stiffness at baseline (cf-PWV: r ¼0.069, p ¼ 0.039; cr-PWV: r ¼ 0.252, p ¼ 0.001). Logistic regressions revealed that higher baseline UA level was an independent predictor for arterial stiffness assessed by cf-PWV at follow-up cross-section (Quartile 3 vs. Quartile 1: OR¼1.449, p ¼ 0.001; Quartile 4 vs. Quartile 1: OR¼2.941, p < 0.001).
CONCLUSIONS Given a higher level of UA in normal range, UA was tightly related with arterial stiffness and it is an independent risk factor and predictor for arterial stiffness which may provide novel stratifications and managements of cardiovascular diseases. 
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RESULTS
Daytime sleepiness was significantly associated with Hhcy (multivariate-model2 OR,1.533;95%CI,1.116-2.105, P ¼ 0.008), but snoring, apnea and sleep disruption were not. sleep dura-tion<6h(multivariate-model 1 OR,1.207;95%CI,1.019-1.430, P ¼ 0.030) and >8h(multivariate-model1 OR,1.206;95%CI,1.055-1.377, P ¼ 0.006) were significant in the age-, sex-adjusted model and multivariateadjusted model 1. However, sleep duration was not significant in multivariate-adjusted model 2. All the three models showed that each superposed sleep variables ('daytime sleepiness and apnea'(multivariate-model2 OR,1.870;95%CI,1.117-3.128, P ¼ 0.017), 'daytime sleepiness, apnea and sleep disruption' (multivariate-model2 OR,2.049;95%CI,1.086-3.863, P ¼ 0.027), 'daytime sleepiness, apnea, sleep disruption and sleep duration>8hours' (multivariate-model2 OR,3.888;95%CI,1.309-11.551, P ¼ 0.015)) was significantly associated with Hyperhomocysteinemia.
CONCLUSIONS Our results present the association between Hhcy and daytime sleepiness, 'daytime sleepiness and apnea', 'daytime sleepiness, apnea and sleep disruption', 'daytime sleepiness, apnea, sleep disruption and sleep duration>8hours'. Besides, the risk of Hhcy increased with the increasing superposition of the sleep variables.
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